- Details
- Elisabeth Heath from the Karmanos Cancer Institute joins Alicia Morgans in a passionate conversation on the importance of patient advocacy, education, and the impact advocacy has on a cancer patients' journey. What resources are out there? How do we really help patients do the best that they can? How do you find advocacy organizations in your community? and, How do you get involved? Drs. Heath and...
|
- Details
- Using various volume and risk criteria used worldwide for the treatment related to docetaxel and abiraterone in metastatic hormone-sensitive prostate cancer, Noel Clarke and colleagues have gathered and correlated large volumes of imaging data on treatment and outcomes from within the UK within the STAMPEDE trial. In his discussion with Charles Ryan, Noel Clarke shares details of the sub-analysis...
|
- Details
- Hossein Jadvar joins Phillip Koo for the last in its series of video presentations in the Society of Nuclear Medicine SNMMI video lecture series. Dr. Jadvar presents on the topic of Radium 223 dichloride use in patients with castrate-resistant prostate cancer. (Length of Interview: 34 min) Biographies: Phillip J. Koo, MD is the Division Chief of Diagnostic Imaging at the Banner MD Anderson Cancer...
|
- Details
- Declan Murphy sits down with Alicia Morgans during the Advanced Prostate Cancer Consensus Conference (APCCC 2019) to discuss men who have node positive but nonmetastatic prostate cancer and how we think about approaching treatment and integrating new imaging modalities into that entire therapeutic paradigm. Two aspects of managing node positive men in regards to surgery were talked about including...
|
- Details
- Noel Clarke presented on the optimization of the treatment of newly diagnosed metastatic prostate cancer at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC). Among the topics he covers in this presentation include the STAMPEDE biomedical imaging group (BIG) and STAMPEDE biomedical research group (BRG) which have incorporated 5,000 CT and bone scans with a target of more than 10,000,...
|
- Details
- Trinity Bivalacqua speaks about the principles of tissue engineering and how this relates to the production of a new urinary like tissue. Biographies: Trinity Bivalacqua, MD, Ph.D., Director of Urologic Oncology, Associate Professor of Urology, Johns Hopkins Medicine, Baltimore, Maryland, United States Related Content: Engineering & Urology Society: "Found in Translation"- Kurt Azarbarzin Read the...
|
- Details
- Alberto Bossi presented on the recommended treatment for men with pathological node-positive prostate cancer. These patients are becoming more common as surgery is being performed on a higher proportion of high-risk patients with positive nodes. Highlighting unanswered questions regarding the treatment of these patients following surgery, Dr. Alberto Bossi mentions several studies that have assess...
|
- Details
- At the Advanced Prostate Cancer Consensus Conference (APCCC) 2019 meeting, Stefano Fanti presented the advantages of PSMA PET-CT in advanced prostate cancer imaging. He highlighted the role of PSMA PET-CT in staging, biochemical recurrence, and therapy planning. Biography: Stefano Fanti, MD, Professor, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Director of Nuclear Medic...
|
- Details
- Abel Ang highlights recently launched devices for endourology. He discusses larger themes about the future of urology and how we can support that growth and innovation. Biography: Abel Ang, Group Chief Executive Officer Advanced MedTech Holdings. Abel has served as the Senior Advisor to the CEO of Greatbatch Inc (NYSE: ITGR), providing guidance relative to the commercialization of medical device t...
|
- Details
- As a follow-up to Dr. Stefano Fanti’s presentation on the advantages of PSMA PET-CT imaging, Dr. Ian Davis from Melbourne discussed some of the pitfalls and disadvantages of PSMA PET-CT in advanced prostate cancer imaging. Biography: Professor Ian Davis, MB, BS, Ph.D., FRAC,P FAChPM, is a medical oncologist, cancer immunologist, clinician-scientist, and NHMRC Practitioner Fellow. He is Professor o...
|
